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To the Editor:
We have read with great interest the review published in your 
journal titled “Hypothesis: Somatic Mosaicism and Parkinson 
Disease (Exp Neurobiol. 2014 Dec;23:271-276),” which discusses 
the “potential” existence of mosaicisms in Parkinson’s disease.
We find it essential to clarify some concepts that we consider 
inadequate/incorrect because they are presented as a new 
hypothesis when in fact our group has already published two 
papers including cases reporting the presence of Mosaicisms 
of Alpha-Synuclein rearrangements associated to Early Onset 
Parkinson Disease (EOPD) cases [1,2].
The paper by Han-Joon Kim and Beom S. Jeon published in 
Dec. 2014 speculates about the possibility that “a somatic mutation 
affecting cells in the central nervous system, including substantia 
nigra dopaminergic neurons could lead to the development of PD 
through the same pathomechanisms of genetic PD even in the 
absence of a germ-line mutation”. Furthermore, the manuscript 
mentions in two sections (in its abstract and in section “PD and 
somatic mosaicism”) that “The study of somatic mosaicism in 
Parkinson disease (PD) is only in its infancy, and a case with 
somatic mutation has not yet been described.”
In our first paper, available online as early as May 2014 
[1], we described the clinical phenotype and the genetic and 
immunohistochemical findings in two unrelated cases with early-
onset PD due to Alpha-Synuclein (SNCA) mosaicism. Although 
Fluorescent In- Situ Hybridization (FISH) results indicated few 
or no rearrangements (i.e. ≤4 FISH probe signals in >20% of 
interphase cells scored) in peripheral leucocytes from either case, 
75% of oral mucosal cells showed triplication and duplication 
of SNCA in case 1 and 43% showed duplication in case 2. This 
duplication occurs in the original chromosome (Fig. 1).
In the “Testing the hypothesis” section, Han-Joon Kim and Beom 
S. Jeon [3], present the need to investigate other tissues other 
than peripheral blood lymphocytes. They suggest evaluating oral 
mucosa cells, something that was conducted and described for 
the first time by us in our above-mentioned paper. Our paper also 
describes the technique used to identify the ectodermal origin 
of the buccal mucosa cells evaluated in both patients (for further 
details, see Fig. 2 in [1]).
The authors Han-Joon Kim and Beom S. Jeon [3], also suggest 
evaluating salivary gland cells in order to increase the chance 
of  finding somatic mosaicisms in PD. In connection with 
this suggestion, we consider it relevant to point out that our 
publication included the evaluation of cells from a biopsy of 
a minor salivary gland, but with the purpose of evaluating the 
presence of immunoreactive augment as a consequence of an 
increase in the alpha-synuclein protein (immunohistochemical 
assays), rather than to detect rearrangements of the Alpha-
Synuclein gene. We decided not to use minor salivary gland cells 
to evaluate gene rearrangements taking into account that salivary 
glands have a mixed endodermal-ectodermal embryological 
origin. It is also worth pointing out that, in patients with Alpha-
Synuclein mosaicisms, the studies performed on samples from the 
minor salivary glands using a rabbit polyclonal SNCA antibody [4] 
showed intense SNCA immunoreactive profiles (Fig. 2).
We agree with the authors’ statement concerning the fact that the 
technology used in the detection of mosaicisms is key. However, 
we consider it relevant to stress that precisely one of the techniques 
suggested by the authors, “High Resolution Melting PCR” based 
on the findings of Prourakis et al. [5], is not the most suitable for 
detection of Copy-Number Variations (CNVs). We would like 
to mention that the de novo mutation rate for CNV can be two 
to four orders of magnitude higher than for Single Nucleotide 
Variations (SNVs) [6], with CNVs arising in mitosis, explaining 
the increasing evidence for CNV mosaicisms in healthy humans, 
including the brain. In our experience, the mosaicism of CNVs 
in SNCA is one of the most important targets when searching for 
PD somatic mosaicism. Therefore, in our paper we postulate that 
techniques such as FISH (low cost, high reproducibility, possibility 
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Fig. 2. Immunohistochemical assays for the detection of alpha-synuclein protein. The figure shows the section of a salivary gland dyed with red 
fluorescence for neurofilament protein (A), the fluorescent DAPI with the genomic DNA in cell nuclei appears in blue (B) and the alpha-synuclein 
protein is detected by a monoclonal antibody and developed in green (C). The overlapping of images (D) highlights that the relative intensity of alpha-
synuclein is larger on the left side of the gland in the image. The increase is not homogeneous in patients with the amplification of alpha-synuclein in 
mosaic. A:200×.
Fig. 1. FISH analysis for Alpha-Synucle-
in gene. Panel A presents an interphase 
of a lymphocyte showing the presence 
of three DNA regions hybridized with 
probes obtained from BAC (Bacterial 
Artificial Chromosomes) containing 
the Alpha-Synuclein gene. Panel B, on 
the right, shows a metaphase where the 
chromosomes carrying the Alpha-Synu-
clein gene can be observed. One of the 
chromosomes can be seen to be more 
intense and have a larger region than 
its homologous pair. Telomere markers 
(green) do not present noticeable diffe-
rences. These results suggest that the du-
plication presents in the same chromo-
some, near the region where the gene is 
located.
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to perform individual tests cell by cell) should be taken into 
account at present, at least until single cell sequencing becomes 
optimized and generally available.
In conclusion, somatic mosaicism has already been confirmed as 
an etiological factor for Parkinson’s disease.
In our experience, the keys for detection of somatic mosaicism in 
PD are:
a) Diagnostic suspicion based on the clinical characteristics 
of patients who present autonomic dysfunction and cognitive 
impairment in addition to EOPD
b) The evaluation of multiple tissues of ectodermal origin that 
are accessible in patients
c) The use of techniques that guarantee individual cell analysis as 
well as the detection of low-level mosaicisms.
Given all of the above, we deem the publication of this letter 
important in order to shed some light about the existence of 
somatic mosaicisms as a relevant (although relatively unexplored) 
etiologic mechanism, not only in PD but in other neurological 
diseases.
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